Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Point-of-Care Testing: Page 2
U.S. government investing $600M in COVID-19 test manufacturing
By
LabPulse.com staff writers
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Some emergency sepsis screening tools inadequate, EU study suggests
By
Matt Limb
Two out of the four internationally recommended screening tools used by emergency medical services are inadequate for recognizing sepsis, say German researchers.
September 26, 2023
Researchers create low-cost, eco-friendly COVID-19 test
By
Matt Limb
Scientists say they have engineered an accurate, low-cost, and eco-friendly COVID-19 test that could dramatically reduce environmental waste.
September 12, 2023
Researchers develop at-home device for diagnosing gingivitis
By
LabPulse.com staff writers
Researchers at the University of Cincinnati in Ohio are developing a device people can use at home to diagnose gingivitis.
September 12, 2023
NIH study shows value of repeat use of COVID-19 antigen tests
By
Nick Paul Taylor
Researchers have published the performance data that prompted the U.S. Food and Drug Administration to revise its position on COVID-19 testing last year.
September 11, 2023
High troponin linked with heightened mortality risk from any cause
By
Matt Limb
A high level of troponin may signal a heightened risk of death from any cause within the next few years, even in the absence of known or suspected cardiovascular disease (CVD), according to recently published research.
August 24, 2023
Capitainer hires Mathias Karlsson as CMO to support self-sampling business
By
Nick Paul Taylor
Karlsson will join Capitainer at the start of September to support its work advancing technology for self-sampling.
August 18, 2023
Experts flag concerns with information provided by consumer microbiome tests
By
Nick Paul Taylor
While physician-ordered tests typically identify specific microorganisms and microbiome states that are associated with particular health disorders, some products aimed at consumers are designed to assess gut health more broadly.
August 17, 2023
FDA tells consumers to trash tests from company involved in illicit lab scandal
By
Nick Paul Taylor
The FDA is unable to confirm how well the tests perform and, as such, there are concerns that the products may not be safe and effective.
August 16, 2023
Quest Diagnostics launches consumer-initiated Alzheimer’s risk assessment test
By
LabPulse.com staff writers
The new test uses the same technology as Quest's clinical AD-Detect Amyloid Beta 42/40 Ratio biomarker test for assessing amyloid beta protein, a recognized marker for Alzheimer’s, which was made available for physicians in early 2022.
August 1, 2023
PBD receives U.S. patent for phage-based tuberculosis diagnostic kit
By
Nick Paul Taylor
PBD is using its expertise in phages to develop Actiphage, a test designed to detect the active mycobacteria that cause tuberculosis in blood samples.
August 1, 2023
Quest Diagnostics launches consumer-initiated genetic test kit
By
LabPulse.com staff writers
The test uses next-generation sequencing (NGS) technology to analyze thousands of DNA variants in the genes associated with the conditions within the test’s scope, searching more regions in the individual’s genome than microarray testing.
July 12, 2023
Previous Page
Page 2 of 41
Next Page